I just posted on my blog about my thoughts of a potential trial for those of us doing well on a TKI but still with residual disease. That is not a small number of patients and our ranks are growing fast.
I have always said ibrutinib was like hitting a triple, but please don't leave us stranded on 3rd base.
Please see bkoffman.blogspot.com
Just back for OSU where I am approaching two years on ibrutinib. Labs are near perfect.
Stay strong. We are all in this together.